Stem Cell Research and Regeneration on Cardiology

An innovative therapeutic approach is the use of cell therapy to counteract reverse ventricular remodelling, the substrate of heart failure and arrhythmias following myocardial infarction. Advantageous cell tissue regeneration combines a complex cellular and molecular advent setting that includes stem cell grafting and differentiation, secretion of anti-inflammatory and angiogenic mediators, and proliferation of endogenous cardiac stem cells. Recent therapeutic approaches involve adipose-derived stem cells, heart-derived stem cells, bone marrow-derived mononuclear cells and mesenchymal stem cells, and combinations of cells. Clinical trials using mesenchymal stem cells and cardiac derived stem cells have been shown to be effective in reducing infarct size and improving the contractility of regional walls.

  • Heart repair
  • Gene Therapy for Cardiovascular Disease
  • Endogenous cardiac stem cell
  • Cardiovascular Cell Therapy Research Network
  • Human Engineered Cardiac Tissues
  • Cardiac stem cell therapy

Related Conference of Stem Cell Research and Regeneration on Cardiology

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Stem Cell Research and Regeneration on Cardiology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in